Awareness and frequency of potential side effects on nonsteroidal anti-inflammatory drugs among the Jordanian patient population

Saudi Medical Journal

Volumn 25, Issue 7, 2004, Pages 907-911

  Albsoul Younes, Abla M ^a   Jabateh, Sawsan K ^a   Abdel Hafiz, Summer M ^a   Al Safi, Saafan A ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; IBUPROFEN; INDOMETACIN; MELOXICAM; NAPROXEN; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ALLERGIC REACTION; ARTHRITIS; ARTICLE; ASEPTIC MENINGITIS; ASTHMA; AWARENESS; BACKACHE; COMMUNITY; CONTROLLED STUDY; DIGESTIVE SYSTEM ULCER; DISEASE EXACERBATION; DRUG USE; DYSPEPSIA; EDEMA; FEMALE; FLATULENCE; FREQUENCY ANALYSIS; GASTROINTESTINAL SYMPTOM; HEADACHE; HEALTH BEHAVIOR; HEARTBURN; HOSPITAL PHARMACY; HUMAN; HYPERTENSION; INCIDENCE; INTERVIEW; JORDAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PAIN; PATIENT COUNSELING; PATIENT EDUCATION; PELVIS PAIN SYNDROME; PHARMACIST; POPULATION RESEARCH; PRESCRIPTION; PROSPECTIVE STUDY; PURCHASING; RANDOMIZATION; STOMACH PAIN; STOMACH ULCER; TOOTH PAIN;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AWARENESS; DICLOFENAC; DRUG UTILIZATION; FEMALE; GASTROINTESTINAL DISEASES; HEALTH SURVEYS; HUMANS; IBUPROFEN; JORDAN; MALE; MIDDLE AGED; NEEDS ASSESSMENT; PATIENT EDUCATION;

EID: 4344589424     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kay EA, Barker AR. Rheumatoid arthritis and osteoarthritis. In: Walker R, Edward C, editor. Clinical pharmacy and therapeutics. Edinburgh (UK): Churchill Livingstone; 2002. p. 779-795.
2. Langman MJ. Risks of anti-inflammatory drug-associated damage. Inflamm Res 1999; 48: 236-238.
3. Hollander D. Gastrointestinal complications and non-steroidal anti-inflammatory drugs: prophylactic and therapeutic strategies. Am J Med 1994; 96: 274-281.
4. Garcia Rodriquez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769-772.
5. Langman MJS, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RF et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-1078.
6. Furst DE. Are there differences among nonsteroidal antiinflammatory drugs? Comparing acetylated salicylates, nonacetylated salicylates, and nonacetylated nonsteroidal antiinflammatory drugs. Arthritis Rheum 1994; 37: 1-9.
7. Lichtenstein DR, Syngal S, Wolfe MM. Non-steroidal anti-inflammatory drugs and gastrointestinal tract. Arthritis Rheum 1995; 1: 5-18.
8. Wallace JL. Non-steroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 1997; 112: 1000-1016.
9. Singh G. Recent considerations in non-steroidal anti-inflammatory drug gastropathy. Am J Med 1998; 105: 31-38.
10. Bures J, Rejchrt S, Kopacova M, Siroky M. [Effects of nonsteroidal anti-inflammatory agents on the gastrointestinal tract] Cas Lek Cesk 2002; 141: 673-679.
11. Radack KL, Deck CC, Bloomfeld SS. Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen. Ann Intern Med 1987; 107: 628-635.
12. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 1993; 153: 477-484.
13. Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure. A meta-analysis. Ann Intern Med 1994; 121: 289-300.
14. Murry MD, Brater DC. Advanced effects of non-steroidal anti-inflammatory drugs on renal function. Ann Intern Med 1990; 112: 559-560.
15. Brater DC. Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition. Am J Med 1999; 13: 65S-70S.
16. Bennett WM, Henrich WL, Stoff JS. The renal effects of non-steroidal anti-inflammatory drugs: summary and recommendations. Am J Kid Dis 1996; 28 (suppl 1): S56-S62.
17. Jenkins C. Recommending analgesics for people with asthma. Am J Ther 2000; 7: 55-61.
18. Taha AS, Hudson NH, Hawkey CJ, Swannell AJ, Trye PN, Cottrell J et al. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med 1996; 334: 1435-1439.
19. Silverstein FE, Graham DY, Senior JR, Davies HW, Struthers BJ, Bittman RM et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. Ann Intern Med 1995; 123: 214-219.
20. Cullen D, Bardhan KD, Eisner M, Kogut DG, Peacock RA, Thomson JM et al. Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users. Aliment Pharmacol Ther 1998; 12: 135-140.
21. Walker JS, Sheather-Reid RB, Carmody JJ. Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis: Support for the concept of 'responders' and 'non-responders'. Arthritis Rheum 1997; 40: 1944-1954.
22. Richard A, James N. Low back pain. N Engl J Med 2001; 344: 363-370.
23. Milsom I, Minic M, Dawood MY, Akin MD, Spann J, Niland NF et al. Comparison of the efficacy and safety of nonprescription doses of naproxen and naproxen sodium with ibuprofen, acetaminophen, and placebo in the treatment of primary dysmenorrhea: a pooled analysis of five studies. Clin Ther 2002; 24: 1384-400.
24. Kolarz G, Mayrhofer F, Neumann K, Singer F. Adverse effects of non-steroidal anti-inflammatory drugs. A prevalence study in Austria. Wien Klin Wochenschr 2003; 115: 41-46.
25. Tanaka A, Hase S, Miyazawa T, Takeuchi K. Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage. J Pharmacol Exp Ther 2002; 300: 754-761.
26. Ruoff GE. Challenges of managing chronic pain in the elderly. Semin Arthritis Rheum 2002; 32 (3 Suppl 1): 43-50.
27. Rollins G. Counseling about anti-inflammatory drugs plays role in peptic ulcer disease outcomes, study reveals. Rep Med Guidel Outcomes Res 2001; 12: 9-10, 12.
28. Lacy CF, Armstrong LL, Goldman MP, Lance LL. Drug information handbook. Lexi-Comp's clinical reference library; 2000. p. 348-350.
29. Blenkinsopp A, Bradley C. Over the Counter Drugs: Patients, society, and the increase in self medication. BMJ 1996; 312: 629-632.
30. Kennedy JG. Over the counter drugs. BMJ 1996; 312: 593-594.
31. Bissell P, Ward PR, Noyce PR. Appropriateness measurement: application to advice-giving in community pharmacies. Soc Sci Med 2000; 51: 343-359.